CARTALAX 20MG-Australia | Silverback Peptides – Research use Only.

Cartalax 20mg (Research Peptide) – Laboratory Grade

Cartalax 20mg is a synthetic short-chain peptide supplied as a lyophilized powder for laboratory research applications. Commonly referenced as AED or T-31, this compound is studied in controlled environments for its interaction with cartilage tissue signaling and connective tissue pathways.

Designed for qualified professionals, Cartalax is utilized in experimental models exploring cellular communication, extracellular matrix dynamics, and chondrocyte-related processes.

Key Features

• 20mg per vial (lyophilized peptide powder)
• High-purity research-grade compound
• Studied in cartilage and connective tissue research models
• Suitable for in-vitro and laboratory-controlled applications only
• Stable format for proper storage and handling

Research Applications

Cartalax is commonly examined in scientific studies related to:

• Cartilage tissue signaling pathways
• Chondrocyte function and extracellular matrix dynamics
• Connective tissue and cellular regulation models
• Musculoskeletal and structural biology research

Important Notice

• For research use only – not for human or veterinary consumption
• Not approved as a therapeutic, drug, or supplement
• Must be handled by qualified professionals in appropriate laboratory settings

Storage & Handling

• Store in a cool, dry environment away from light
• Follow proper laboratory protocols for reconstitution and use
• Refer to batch-specific Certificate of Analysis where available

Why Choose Cartalax 20mg

This peptide is part of a class of compounds investigated for their role in cellular signaling and structural tissue research, making it relevant for laboratories studying cartilage biology and connective tissue systems.